Popular Articles

HydroCision Introduces The "Walk In/Walk Out" Option For Treatment Of Herniated Discs
HydroCision Inc. announced the launch of its new SpineJet® Percutaneous Access Set for use in herniated disc procedures using its novel cutting-with-water fluidjet technology. "These instruments will assist the company to more quickly capitalize on the double digit growth of the minimally invasive percutaneous discectomy market," says Doug Daniels. "A large driver of procedural growth has been patients who seek out surgeons who perform minimally invasive procedures to reduce down time from work in these tough economic times. This has led to rapid adoption of this new and evolving technique for the treatment of lower back pain by a growing number of neurosurgeons, orthopedic surgeons and interventional pain physicians. This trend has created the need for new instruments that can work through very small incisions."
buy viagra
FDA Accepts SNDA For Alternative Dosing Regimen For Dacogen(R) (decitabine For Injection) To Treat Patients With Myelodysplastic Syndromes (MDS)
Eisai Corporation of North America announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company"s supplemental new drug application (sNDA) for an alternative five-day dosing regimen for Dacogen(R) (decitabine for injection) to treat patients with myelodysplastic syndromes (MDS). MDS is a potentially life-threatening group of bone marrow diseases that limit the production of functional blood cells.
plan for health
News of the day
Landmark Data Presented At The British Society For Allergy And Clinical Immunology Shows Hay Fever Vaccine Could Be A Reality
New data presented at the British Society for Allergy and Clinical Immunology (BSACI) annual meeting demonstrate that Grazax® is the first tablet treatment to provide sustained disease control in patients with grass pollen rhinoconjunctivitis (hay fever) after the treatment period ended. This is the first time disease modification by sublingual allergy immunotherapy tablets has been achieved; effectively re-setting the immune system to reduce future allergic reactions to grass pollen.
Health Insurance

Jaloma Pacifiers Recalled Due To Choking Hazard

The Connecticut Department of Consumer Protection is notifying consumers about a voluntary recall announced by the U.S. Consumer Product Safety Commission. The recalled Jaloma Pacifiers were sold in retail stores in New Jersey and New York from February 2008 through March 2009, for approximately $1.00. Although not sold in Connecticut stores, this recalled product may have been purchased while visiting the above noted states or may have been sent to Connecticut as a gift. The pacifiers were manufactured in Mexico and imported by Gromex Inc., of Passaic, New Jersey. Although no injuries and/or incidents have been reported, the potential for injury is high due to the pacifier mouth guard and the ventilation holes are too small and fail to meet federal safety standards, for this reason, the pacifier poses a choking hazard to young children. This pacifier has a ring-shaped handle and a round-shaped mouth guard with two ventilation holes. "Jaloma" is printed on the handle side of the mouth guard and the nipple has a gel-like liquid inside. Consumer Protection Commissioner Jerry Farrell, Jr., strongly recommends that parents check their children"s pacifiers for this product and if found, immediately remove from the child"s use and contact Gromex for a full refund or exchange. For additional information, please contact Gromex collect at (973) 458-9399, Monday through Friday, from 9:00 a.m. to 5:00 p.m., Eastern Time. Connecticut Department of Consumer Protection


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):